Emmaus Life Sciences Provides Update in Response to the Coronavirus (COVID-19) Pandemic
March 24, 2020 08:00 ET
|
Emmaus Life Sciences
TORRANCE, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease (SCD) treatment, announced today several steps it has taken in response...
Emmaus Life Sciences Announces Equity Purchase Agreement for up to $25 Million with Lincoln Park Capital
March 03, 2020 08:00 ET
|
Emmaus Life Sciences
TORRANCE, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today the execution of a purchase agreement for...
Emmaus Life Sciences Reports Preliminary Gross Sales for the Three Months Ended December 31, 2019
February 05, 2020 08:00 ET
|
Emmaus Life Sciences
-- Company Reports Highest Gross Monthly Sales of 2019 and Total Gross Sales of $7.8 Million in the Fourth Quarter -- TORRANCE, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc....
Emmaus Life Sciences Reports Positive Top-Line Preliminary Results in First Patient in Diverticulosis Pilot Trial
January 29, 2020 08:00 ET
|
Emmaus Life Sciences
TORRANCE, Calif., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today the top-line preliminary results in the first...
Emmaus Life Sciences Expresses Concerns Over Inaccuracies in Draft Report Issued by ICER (Institute for Clinical and Economic Review)
January 27, 2020 08:00 ET
|
Emmaus Life Sciences
TORRANCE, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, responded today to the draft evidence report by ICER dated...
Emmaus Life Sciences Announces a New Adherence Program for Its Sickle Cell Disease Patients
January 06, 2020 08:00 ET
|
Emmaus Life Sciences
TORRANCE, Calif., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, is pleased to announce a new adherence program available to...
Emmaus Life Sciences Announces First Purchase Order from its Partnership with taiba Healthcare
December 31, 2019 16:01 ET
|
Emmaus Life Sciences
TORRANCE, Calif., Dec. 31, 2019 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today reported that it received the initial purchase order...
Emmaus Life Sciences Announces Update of its Partnership with taiba Healthcare to Expand Patient Access for Sickle Cell Disease Treatment in the Middle East and North Africa (MENA) Region
December 23, 2019 16:01 ET
|
Emmaus Life Sciences
TORRANCE, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today reported that it expects to receive shortly the initial...
Emmaus Life Sciences Reports 2019 Third Quarter Financial Results
November 12, 2019 08:00 ET
|
Emmaus Life Sciences
-- Net Revenues Increased 25% Year-Over-Year,Company Opens and Expands Class of Trade with Community Hematologists and Correctional Facilities -- TORRANCE, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) --...
Emmaus Life Sciences Announces Equity Investment from a Corporate Investor
October 29, 2019 08:00 ET
|
Emmaus Life Sciences
Company Enters Into Common Stock Purchase Agreement with Vivozon, Inc. TORRANCE, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease...